Scott Schlackman Buys 2,500 Shares of Medifast (NYSE:MED) Stock

Medifast Inc (NYSE:MED) Director Scott Schlackman purchased 2,500 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average cost of $12.65 per share, with a total value of $31,625.00. Following the completion of the purchase, the director directly owned 28,049 shares in the company, valued at $354,819.85. The trade was a 9.79% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Scott Schlackman also recently made the following trade(s):

• On Monday, May 11th, Scott Schlackman purchased 2,500 shares of Medifast stock. The shares were acquired at an average cost of $12.53 per share, with a total value of $31,325.00.

Medifast Stock Performance

Shares of MED stock opened at $12.48 on Thursday. Medifast Inc has a 52-week low of $9.22 and a 52-week high of $15.46. The firm has a market capitalization of $138.78 million, a P/E ratio of -6.82 and a beta of 0.55. The stock has a 50 day moving average price of $10.70 and a 200 day moving average price of $11.09.

Medifast (NYSE:MED) last issued its quarterly earnings results on Monday, May 4th. The specialty retailer reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.36. Medifast had a negative return on equity of 4.80% and a negative net margin of 5.78%.The firm had revenue of $76.04 million during the quarter, compared to analyst estimates of $69.20 million. Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. As a group, sell-side analysts forecast that Medifast Inc will post -2 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. BNP Paribas Financial Markets increased its holdings in Medifast by 103.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,338 shares of the specialty retailer’s stock worth $32,000 after purchasing an additional 1,187 shares during the period. Quantbot Technologies LP purchased a new position in shares of Medifast in the 3rd quarter valued at $37,000. Intesa Sanpaolo Wealth Management purchased a new position in shares of Medifast in the 4th quarter valued at $47,000. State of Wyoming purchased a new position in shares of Medifast in the 4th quarter valued at $59,000. Finally, Strs Ohio purchased a new position in shares of Medifast in the 1st quarter valued at $78,000. 95.51% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on the company. Wall Street Zen upgraded Medifast from a “sell” rating to a “hold” rating in a report on Saturday, March 21st. Weiss Ratings downgraded Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Finally, Stephens reduced their price objective on Medifast from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Thursday, February 19th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Medifast has a consensus rating of “Reduce” and a consensus price target of $12.00.

Medifast Company Profile

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.